Page last updated: 2024-11-08

2-methylamino-1,4-naphthoquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methylamino-1,4-naphthoquinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID464135
CHEMBL ID240319
CHEMBL ID164359
SCHEMBL ID4540326
MeSH IDM0514282

Synonyms (16)

Synonym
2-(methylamino)-1,4-naphthoquinone
14423-00-8
1,4-naphthalenedione, 2-(methylamino)-
2-(methylamino)naphthalene-1,4-dione
CHEMBL240319
CHEMBL164359
2-methylamino-[1,4]naphthoquinone
AKOS004910396
KUC111411N
ksc-293-047a
2-(methylamino)naphthoquinone
AK-693/33372040
SCHEMBL4540326
2-methylamino-1,4-naphthoquinone
2-(methylamino)naphthoquinone #
DTXSID20162654

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Some such compounds are known, however, to be toxic to both animals and humans."( Structure-activity relationships in the haemolytic activity and nephrotoxicity of derivatives of 1,2- and 1,4-naphthoquinone.
Munday, CM; Munday, R; Smith, BL,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID19838Partition coefficient (logP)1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
AID19426HPLC capacity factor (logK)1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
AID736843Therapeutic index, ratio of cytotoxic TC50 for mouse HT22 cells to neuroprotective PD50 for mouse HT22 cells2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.
AID1807841Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability by MTT assay2021Bioorganic & medicinal chemistry letters, 12-01, Volume: 53Synthetic enamine naphthoquinone derived from lawsone as cytotoxic agents assessed by in vitro and in silico evaluations.
AID308238Inhibition of pig pancreatic elastase2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
AID736842Neurotoxicity in mouse HT22 cells assessed as cell viability after 24 hrs by MTS assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.
AID1807842Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability by MTT assay2021Bioorganic & medicinal chemistry letters, 12-01, Volume: 53Synthetic enamine naphthoquinone derived from lawsone as cytotoxic agents assessed by in vitro and in silico evaluations.
AID736844Neuroprotective activity in mouse HT22 cells assessed as prevention from glutamate-induced oxidative cell death by MTS assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.
AID1807844Antiproliferative activity against human SNB-19 cells assessed as reduction in cell viability by MTT assay2021Bioorganic & medicinal chemistry letters, 12-01, Volume: 53Synthetic enamine naphthoquinone derived from lawsone as cytotoxic agents assessed by in vitro and in silico evaluations.
AID1807843Antiproliferative activity against human HL-60 cells assessed as reduction in cell viability by MTT assay2021Bioorganic & medicinal chemistry letters, 12-01, Volume: 53Synthetic enamine naphthoquinone derived from lawsone as cytotoxic agents assessed by in vitro and in silico evaluations.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.01 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]